By Angelo Young “To give you an idea of how much Americans are getting gouged on their purchases of medicine, consider this: Over the past three years, the cost of six commonly used drugs categories, including treatments for asthma, diabetes,…
AIR IMPACT
Recognition of AIR research, opinions, and people in the media and elsewhere
Is our focus on quarterly earnings hurting the U.S. economy
By Dwyer Gunn “Last week, Jamie Dimon, the chief executive officer of JPMorgan Chase, and Warren Buffett, the well-known value investor and chairman of Berkshire Hathaway, penned an op-ed in the Wall Street Journal urging public companies to “consider moving away from providing…
U.S. senators challenge the S.E.C. on share buybacks
By Steve Denning “The decades-long diversion of business income to shareholders has resulted in a soaring stock market but also stagnating incomes for most of the population. If this gargantuan transfer of assets to the existing owners of shares is…
Senators join call for revisiting SEC stock buyback practices and rules
By Hazel Bradford “A group of Democratic senators called Thursday for the Securities and Exchange Commission to hear from the public about reviewing rules covering stock buybacks. Led by Senate Minority Leader Chuck Schumer of New York and Sens. Chris…
Letter from 21 Senate Democrats to Jay Clayton, Chair of the Securities and Exchange Commission
By 21 Senate Democrats Letter from 21 Senate Democrats to Jay Clayton, Chair of the Securities and Exchange Commission, asking the SEC “to open a public comment period to review the SEC’s current rules around share repurchases “We write concerns…
How Big Pharma was captured by the one percent
By Alexander Zaitchik “Donald Trump’s plan to lower prescription drug prices, announced May 11 in the Rose Garden, is a wonky departure for the president. In his approach to other signature campaign pledges, Trump has selected blunt-force tools: concrete walls, trade wars, ICE…
Support for GOP tax scam drops as corporate America gorges on stock buybacks
By Andrea Germanos “Roughly six months after President Donald Trump put his signature on the GOP “tax scam,” a new poll reveals dwindling support for the corporate-friendly law whose benefits went mostly to the nation’s wealthiest.”… [Click HERE to read the full…
Shareholders are overrated
By Susan Holmberg “For over four decades, corporations have shifted their strategy to one singular goal: maximizing payouts for shareholders. While corporate America once invested in their companies for the long term—by paying their workers well, by making capital investments,…
Stock buybacks and corporate cashouts
By Robert J. Jackson “Thank you so much, Neera, for that very kind introduction. I’ve long admired all that you and everyone here at the Center for American Progress do to promote a progressive economic agenda. And I share your…
A prize masking a dilemma: the problem with stock buybacks
By Arthur S. Guarino “Stock buybacks are gaining in popularity among publicly-owned corporations and many of their shareholders. However, the financial implications for the corporation could be masking serious long-term problems and possibly hurt rather than help shareholders.”… [Click HERE…
